Skip to main content
padlock icon - secure page this page is secure

Therapeutic Prospects in Preeclampsia – A Mini-Review

Buy Article:

Price: $63.00 + tax (Refund Policy)

Background: Preeclapmsia (PE) is characterized by early onset symptoms such as elevated blood pressure, proteinuria and edema in the pregnant woman, and may result in seizures in the affected woman. Currently, there are no therapeutic drugs available to treat this condition, but there are interventions to regulate the symptoms based on the gestational period of the fetus, although the largely favored option is the delivery of the fetus and placenta.

Objective: A search for biomolecules was conducted associated with PE so as to identify diagnostic markers and therapeutic leads.

Results: The literature search resulted in the identification of biomolecules such as Corin and placental protein 13 (PP13), among others that are associated with PE. Thereby, giving an insight into the various mechanistic pathways involved in the causation of PE. However, it is also evident that PE cannot be solely attributed to any single mechanism but is due to an interplay of different factors that have led to the development of this disease condition.

Conclusion: The identified biomarkers would ultimately help in understanding this complex disease and perhaps lead to the discovery of potential effective molecular targets for clinical trials, thereby providing a valuable therapeutic option for affected pregnant women.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Adenosine; Biomarkers; Corin; Hypertension; Placental Protein 13; Preeclampsia

Affiliations: Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore - 117594.

Appeared or available online: March 14, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more